Suchergebnisse - "Vertosick, Emily"

PubPharm (6)

1

Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort

enthalten in: BJU international | 2021

von Lonergan, P. | Vertosick, E. | Assel, M. | +10

2

Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels

enthalten in: The Prostate | 2020

von Li, W. | Bicak, M. | Sjoberg, D. | +6

3

Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years

enthalten in: The Journal of urology | 2020

von Vertosick, E. | Häggström, C. | Sjoberg, D. | +5

CommentIn: J Urol. 2020 Aug;204(2):287. - PMID 32432506

4

Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival

enthalten in: European urology | 2018

von Li, W. | Middha, M. | Bicak, M. | +11

CommentIn: Eur Urol. 2018 Dec;74(6):720-721. - PMID 30029823

5

Value of a Statistical Model Based on Four Kallikrein Markers in Blood, Commercially Available as 4Kscore, in All Reasonable Prostate Biopsy Subgroups

enthalten in: European urology | 2018

von Vickers, A. | Vertosick, E. | Sjoberg, D.

6

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen

enthalten in: BMC medicine | 2014

von Vickers, A. | Sjoberg, D. | Ulmert, D. | +8

1
[1]